The purpose of this study is to find out how many participants are interested in a surgical preventive procedure after watching an educational video. Before and after watching the video, participants will complete questionnaires in the clinic.

Inclusion Criteria:

Part I

• Age ≥45 years
• Scheduled visit with a nongynecologic surgeon
• Female or assigned female at birth

Part II

• Age ≥45 years

• At least one in situ fallopian tube

• No desire or plan to have children in the future

• Average risk of developing ovarian cancer

  ° Note: Average risk patients are defined as patients with no known genetic risk factor for developing ovarian cancer. Patients who, after obtaining family history, are suspected to have a hereditary ovarian cancer syndrome but have not yet been tested, will be referred for genetic evaluation.

• Planned nongynecologic, intraabdominal, or pelvic surgery

• Deemed to be a suitable candidate by gynecologic surgeon and primary nongynecologic surgeon (for example, on the basis of surgical history and current malignancy status)

• Approved and signed informed consent

Exclusion Criteria:

Part I

• Not fluent in English or Spanish

  ° If there is a non-english or non-spanish speaking participant who is a strong candidate and meets all other criteria for Part 2, they are able to go directly onto Part 2 without completing Part 1. (Please see additional details in section 4.1 and 7.0.)

• Known inherited ovarian cancer susceptibility

Part II

• Personal history of a gynecologic malignancy
• Carrier of a hereditary breast or ovarian cancer variant (e.g., BRCA1, BRCA2, BRIP1, PALB2, RAD51C, RAD51D, MLH1, MSH2, MSH6, PMS2)
• Suspicious ovarian, fallopian tube, or uterine lesion on preoperative imaging
• Previous bilateral salpingectomy or bilateral salpingo-oophorectomy
• Presence of ESSURE, or other tubal-implanted birth control at the time of surgery
• Current pregnancy
• Emergent procedure or emergency procedure that has to be completed within 24 hours where clinical consent occurs in the inpatient setting or where the patient's immediate well-being is in danger or condition may be life threatening
• Primary surgeon anticipates that OS will add significant time (>30-40min) to the planned procedure.
• Inability to access the pelvis (ex., patient prone/lateral position) during the planned procedure.
• Known history of pelvic fibrosis or significant adhesions.
• Procedures with palliative intent only

• Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.